Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Announcing the new Tapestri scMRD Assay for AML. Learn More
X
Scientific presentation

Dissecting intratumoral heterogeneity in localized HR+/HER2– breast cancer using single-cell DNA sequencing


Alicia Tran Dien, PhD
Description

Localized breast cancer (LBC) embraces multiple genetic mutagenic events during the tumour development. Each mutation, at both gene copy number variant (CNV) and singlenucleotide variant (SNV) levels, may generate distinct cellular subclones within the same tumour, resulting in intra-tumoral heterogeneity (ITH). Although ITH is a risk factor for therapy resistance and relapse, its intrinsic nature at the single-cell level remains obscure. Here, we investigate the genetic mechanism underlying ITH in a cohort of hormone receptor-positive/ HER2- negative (HR + /HER2 – ) LBC.



VIEW


Scientific presentation
Overview on Mission Bio’s Applications
Simone Formisano
Mission Bio EU Heme Symposium (2022)
Scientific presentation
Single Cell Core Facility Services at Josep Carreras Institute
Caterina Mata Garcia, PhD
Mission Bio EU Heme Symposium (2022)
Scientific presentation
EU Heme Symposium Panel Discussion
Manel Esteller, MD, PhD
Maria Paola Martelli, MD PhD, Renee Beekman, PhD
Ferran Nadeu, PhD
Mission Bio EU Heme Symposium (2022)
Scientific presentation
Monitoring of Leukemia Clones in B-cell Acute Lymphoblastic Leukemia at Diagnosis and During Treatment by Single-cell DNA Amplicon Sequencing
Sarah Meyers, PhD
Mission Bio EU Heme Symposium (2022)
REQUEST QUOTE